PHIO PHARMACEUTICALS CORP. Capital Expenditures Incurred but Not yet Paid
PHIO PHARMACEUTICALS CORP. (PHIO) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2021-05-13
- PHIO PHARMACEUTICALS CORP. capital expenditures incurred but not yet paid for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. capital expenditures incurred but not yet paid for the quarter ending 2020-12-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. capital expenditures incurred but not yet paid for the quarter ending 2020-03-31 was $18.00K.
- PHIO PHARMACEUTICALS CORP. capital expenditures incurred but not yet paid for the quarter ending 2019-12-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. capital expenditures incurred but not yet paid for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- PHIO PHARMACEUTICALS CORP. capital expenditures incurred but not yet paid for fiscal 2019 was $33.00K.
- PHIO PHARMACEUTICALS CORP. capital expenditures incurred but not yet paid for fiscal 2018 was $0.00.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2021-05-13 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 10-K · filed 2021-03-25 | ||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 | |||
| 2020-03-31 | $18.00K 10-Q · filed 2021-05-13 | $18.00K derived: sum of 2 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $33.00K 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $33.00K 10-Q · filed 2020-11-10 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-12 | $0.00 derived: sum of 2 quarters · filed 2020-05-12 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $0.00 10-K · filed 2020-03-26 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |